
Wedbush reiterated an Outperform rating and $230 price target on Palantir after the company beat Q2 fiscal 2026 expectations and raised full-year guidance. Fiscal 2026 revenue is now projected at $7.650 billion-$7.662 billion, up from $7.182 billion-$7.198 billion and above the $7.240 billion Street estimate, while adjusted operating income rose to $4.440 billion-$4.452 billion and free cash flow to $4.200 billion-$4.400 billion. U.S. commercial revenue is expected to grow 120% year over year, with CEO Alex Karp guiding to 100% growth in fiscal 2027.
PLTR is moving from a “prove-it” story to a scarcity asset: in a market where most software names are decelerating, sustained triple-digit U.S. commercial growth plus higher guidance makes it one of the few AI beneficiaries with visible near-term operating leverage. The key second-order effect is that every upside revision increases the denominator problem for skeptics — valuation stops being a multiple question and becomes a duration question, with the stock likely to remain momentum-driven as long as revenue re-acceleration persists. The bigger implication is competitive: if enterprise buyers are still expanding AIP spend despite broader budget scrutiny, this suggests AI platform consolidation is underway and point solutions are likely to face longer sales cycles. That should pressure adjacent software vendors that sell workflow, analytics, or decision-support tools without an embedded deployment moat; the market may start rewarding platforms with hard-to-replicate integration and data layers while de-rating “AI wrapper” names. Risk is mostly a time-horizon mismatch. In the next 1-3 months, the stock can keep working on guidance revisions and analyst target resets, but over 6-12 months the bar rises sharply: any slowdown in U.S. commercial growth below the current implied trajectory would trigger multiple compression first, even if absolute growth remains strong. The main contrarian point is that consensus may be underestimating how much of the upside is already in the stock; when expectations embed perfection, even excellent execution can translate into flat forward returns if the next catalyst is merely confirmation rather than acceleration. The cleanest setup is to own the name tactically into continued post-earnings estimate revisions, but size it as a momentum trade rather than a long-duration fundamental compounder. A miss on guidance cadence or evidence of deal elongation would likely hit the stock harder than peers because the bull case is now built on sustained re-acceleration, not just profitability.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
strongly positive
Sentiment Score
0.72
Ticker Sentiment